Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC
GLOBETECH MEDIA

Indian Spice Ingredient Kills Cancer Cells

By BiotechDaily International staff writers
Posted on 10 Nov 2009
A new study has revealed that curcumin, a compound found in the spice Turmeric, kills esophageal cancer cells in the laboratory via an unforeseen cell-death mechanism.

Researchers at University College Cork (UCC, Ireland) found that curcumin treatment of an esophageal cancer cell line reduced the viability of all cells within 24 hours of treatment. Since the common path of cell death is apoptosis--a cell suicide path triggered by proteins called caspases--the researchers added a molecule that stops the caspases triggering apoptosis, and found that it made no difference to the number of cells that died. The curcumin seems to induce cell death by a mechanism that was not reliant on apoptosis induction, and in fact, the cells began to digest themselves. The study was published in the October 28, 2009, issue of the British Journal of Cancer.

"The incidence of esophageal cancer has gone up by more than a half since the 70's, particularly in the Western world, and this is thought to be linked to rising rates of obesity, alcohol intake and reflux disease, so finding ways to both treat and prevent this disease is extremely important,” said study coauthor Professor Gerald O'Sullivan, M.D., Ph.D., who heads the Cork Cancer Research Center (CCRC) at UCC. "The development of natural compounds as chemo-preventative agents is also a very promising area of research.”

Curcumin is the principal curcuminoid of the ginger family (Zingiberaceae); the other two curcuminoids are desmethoxycurcumin and bis-desmethoxycurcumin. The curcuminoids are polyphenols and thus responsible for the yellow color of turmeric, which has been used historically as a component of Indian Ayurvedic medicine since 1900 BCE to treat a wide variety of ailments. A recent study on curcumin effects on cancer stated that curcumin modulates growth of tumor cells through regulation of multiple cell signaling pathways, including the cell proliferation pathway, cell survival pathway, caspase activation pathway, tumor suppressor pathway, death receptor pathway, mitochondrial pathways, and the protein kinase pathway.

Related Links:

University College Cork



WATERS CORPORATION

Channels

Genomics/Proteomics

view channel
Image: Exosomes loaded with catalase (shown in red) efficiently interact with neurons (shown in black) to protect them from the effects of Parkinson\'s disease (Photo courtesy of Dr. Elena Batrakova, University of North Carolina).

Exome Delivery of the Anti-Oxidant Catalase Reduces Parkinson's Disease Symptoms in Mouse Model

The exosome delivery of the antioxidant enzyme catalase was shown to dramatically reduce symptoms of Parkinson's disease (PD) in a mouse model. Exosomes are cell-derived vesicles that are present in... Read more

Drug Discovery

view channel
Image: Star-like glial cells in red surround alpha-beta plaques in the cortex of a mouse with a model of Alzheimer\'s disease (Photo courtesy of Strittmatter laboratory/Yale University).

Experimental Cancer Drug Reverses Symptoms in Mouse Model of Alzheimer's Disease

An experimental, but clinically disappointing drug for treatment of cancer has been found to be extremely effective in reversing the symptoms of Alzheimer's disease (AD) in a mouse model.... Read more

Lab Technologies

view channel
Image: The gene assembly robot, the GeneTheatre (Photo courtesy of Analytik Jena AG).

Genomic Research Laboratories Await New Compact Liquid Handling System

A small footprint benchtop liquid handler that automates multiple gene assembly tasks and associated procedures such as PCR setup is now available for use by biotech and genomic research laboratories.... Read more

Business

view channel

NanoString and MD Anderson Collaborate on Development of Novel Multi-Omic Expression Profiling Assays for Cancer

The University of Texas MD Anderson Cancer Center (Houston, TX, USA) and NanoString Technologies, Inc. (Seattle, WA, USA) will partner on development of a revolutionary new type of assay—simultaneously profiling gene and protein expression, initially aiming to discover and validate biomarker signatures for immuno-oncology... Read more
 

Events

27 May 2015 - 28 May 2015
02 Jun 2015 - 03 Jun 2015
15 Jun 2015 - 18 Jun 2015
Copyright © 2000-2015 Globetech Media. All rights reserved.